title: Is there a critical period for mossy fiber sprouting in a mouse model of temporal lobe epilepsy?
abstract: OBJECTIVE
  Dentate granule cell axon (mossy fiber) sprouting creates an aberrant positive-feedback circuit that might be epileptogenic. Presumably, mossy fiber sprouting is initiated by molecular signals, but it is unclear whether they are expressed transiently or persistently. If transient, there might be a critical period when short preventative treatments could permanently block mossy fiber sprouting. Alternatively, if signals persist, continuous treatment would be necessary. The present study tested whether temporary treatment with rapamycin has long-term effects on mossy fiber sprouting.
  
  
  METHODS
  Mice were treated daily with 1.5 mg/kg rapamycin or vehicle (i.p.) beginning 24 h after pilocarpine-induced status epilepticus. Mice were perfused for anatomic evaluation immediately after 2 months of treatment ("0 delay") or after an additional 6 months without treatment ("6-month delay"). One series of sections was Timm-stained, and an adjacent series was Nissl-stained. Stereologic methods were used to measure the volume of the granule cell layer plus molecular layer and the Timm-positive fraction. Numbers of Nissl-stained hilar neurons were estimated using the optical fractionator method.
  
  
  RESULTS
  At 0 delay, rapamycin-treated mice had significantly less black Timm staining in the granule cell layer plus molecular layer than vehicle-treated animals. However, by 6-month delay, Timm staining had increased significantly in mice that had been treated with rapamycin. Percentages of the granule cell layer plus molecular layer that were Timm-positive were high and similar in 0 delay vehicle-treated, 6-month delay vehicle-treated, and 6-month delay rapamycin-treated mice. Extent of hilar neuron loss was similar among all groups that experienced status epilepticus and, therefore, was not a confounding factor. Compared to naive controls, average volume of the granule cell layer plus molecular layer was larger in 0 delay vehicle-treated mice. The hypertrophy was partially suppressed in 0 delay rapamycin-treated mice. However, 6-month delay vehicle- and 6-month delay rapamycin-treated animals had similar average volumes of the granule cell layer plus molecular layer that were significantly larger than those of all other groups.
  
  
  CONCLUSIONS
  Status epilepticus-induced mossy fiber sprouting and dentate gyrus hypertrophy were suppressed by systemic treatment with rapamycin but resumed after treatment ceased. These findings suggest that molecular signals that drive mossy fiber sprouting and dentate gyrus hypertrophy might persist for >2 months after status epilepticus in mice. Therefore, prolonged or continuous treatment might be required to permanently suppress mossy fiber sprouting.
authors.affiliation: Department of Comparative Medicine, Stanford University, Stanford, California 94305, USA.
authors.forename: Felicia H
authors.initials: FH
authors.lastname: Lew
authors.forename: Paul S
authors.initials: PS
authors.lastname: Buckmaster
mesh_terms: D000818:Animals; D003423:Critical Period, Psychological; D004195:Disease Models, Animal; D004833:Epilepsy, Temporal Lobe / Q000139:chemically induced / Q000473:pathology* / Q000517:prevention & control; D006624:Hippocampus / Q000473:pathology / Q000503:physiopathology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D051379:Mice; D019599:Mossy Fibers, Hippocampal / Q000187:drug effects / Q000502:physiology*; D018721:Muscarinic Agonists / Q000633:toxicity; D009474:Neurons / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D010862:Pilocarpine / Q000633:toxicity; D020123:Sirolimus / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D018721:Muscarinic Agonists; D010862:Pilocarpine; D020123:Sirolimus
references.citation: Anat Rec. 1991 Dec;231(4):482-97
references.pmid: 1793176
references.citation: Brain Res. 1989 Aug 28;495(2):387-95
references.pmid: 2569920
references.citation: J Comp Neurol. 1997 Sep 1;385(3):385-404
references.pmid: 9300766
references.citation: Brain. 2000 Jan;123 ( Pt 1):19-30
references.pmid: 10611117
references.citation: J Neurosci. 2007 May 30;27(22):5967-75
references.pmid: 17537967
references.citation: J Comp Neurol. 1995 Feb 20;352(4):515-34
references.pmid: 7721998
references.citation: Neuroscience. 1999 Mar;89(1):157-66
references.pmid: 10051225
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10432-7
references.pmid: 9294228
references.citation: J Neurosci. 2007 May 23;27(21):5546-58
references.pmid: 17522300
references.citation: Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94
references.pmid: 4110397
references.citation: J Physiol. 1970 Feb;206(2):419-36
references.pmid: 5498493
references.citation: J Neurosci. 2009 Jun 24;29(25):8259-69
references.pmid: 19553465
references.citation: Ann Neurol. 2008 Apr;63(4):444-53
references.pmid: 18389497
references.citation: Brain Res. 1990 Sep 10;527(1):1-6
references.pmid: 2282474
references.citation: Ann Neurol. 1989 Sep;26(3):321-30
references.pmid: 2508534
references.citation: Neuroscience. 1991;42(2):351-63
references.pmid: 1716744
references.citation: J Neurosci. 2010 Feb 10;30(6):2051-9
references.pmid: 20147533
references.citation: Ann Neurol. 2004 Jun;55(6):860-70
references.pmid: 15174021
references.citation: Ann Neurol. 1998 Dec;44(6):923-34
references.pmid: 9851437
references.citation: J Neurosci. 2009 May 27;29(21):6964-72
references.pmid: 19474323
references.citation: Neurobiol Dis. 2010 Oct;40(1):193-9
references.pmid: 20566381
references.citation: J Neurosci. 1997 May 15;17(10):3727-38
references.pmid: 9133393
references.citation: Neurosci Lett. 2007 Feb 27;414(1):57-60
references.pmid: 17223264
references.citation: Biochim Biophys Acta. 2008 Jan;1784(1):116-32
references.pmid: 17913600
references.citation: Exp Neurol. 2007 Jun;205(2):569-82
references.pmid: 17475251
references.citation: Brain Res. 1980 Jan 20;182(1):1-9
references.pmid: 7350980
references.citation: Dis Model Mech. 2009 Jul-Aug;2(7-8):389-98
references.pmid: 19470613
references.citation: J Cereb Blood Flow Metab. 2007 May;27(5):939-49
references.pmid: 16955078
references.citation: Neuroscientist. 2010 Jun;16(3):253-75
references.pmid: 20479472
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12923-8
references.pmid: 14534328
references.citation: J Neurosci. 2001 Nov 1;21(21):8523-37
references.pmid: 11606641
references.citation: Ann Neurol. 2001 Dec;50(6):708-17
references.pmid: 11761468
references.citation: Exp Brain Res. 1995;102(3):423-8
references.pmid: 7737389
references.citation: J Neurosci. 2011 Feb 9;31(6):2337-47
references.pmid: 21307269
references.citation: J Neurosci. 1990 Jan;10(1):267-82
references.pmid: 1688934
references.citation: J Neurosci. 2005 Sep 14;25(37):8391-401
references.pmid: 16162921
references.citation: J Neurosci. 2007 Aug 29;27(35):9400-7
references.pmid: 17728453
references.citation: J Neurosci. 1993 Apr;13(4):1511-22
references.pmid: 8463831
references.citation: BMC Genomics. 2010 Apr 08;11:230
references.pmid: 20377889